Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic

被引:46
|
作者
Luchetti, Michele Maria [1 ]
Benfaremo, Devis [1 ]
Campanati, Anna [2 ,3 ]
Molinelli, Elisa [2 ,3 ]
Ciferri, Monia [1 ]
Cataldi, Serena [1 ]
Capeci, William [1 ]
Di Carlo, Marco [4 ,5 ]
Offidani, Anna Maria [2 ,3 ]
Salaffi, Fausto [4 ,5 ]
Gabrielli, Armando [1 ]
机构
[1] Univ Politecn Marche, Dipartimento Sci Cliniche & Mol, Clin Med, Via Tronto 10-A, I-60126 Ancona, Italy
[2] Azienda Osped Univ Umberto IGM Lancisi G Salesi, Clin Dermatol, I-60020 Ancona, Italy
[3] Univ Politecn Marche, Dipartimento Sci Clin & Mol, I-60020 Ancona, Italy
[4] Univ Politecn Marche, Dipartimento Sci Clin & Mol, Clin Reumatol, Jesi 60035, Italy
[5] Osped Carlo Urbani, Jesi 60035, Italy
关键词
Dermo-rheumatologic clinic (DERC); Health related quality of life; psoriatic disease; SOCIETY CLASSIFICATION CRITERIA; PLACEBO-CONTROLLED TRIAL; EFFICACY; SPONDYLOARTHRITIS; SAFETY; RECOMMENDATIONS; DERMATOLOGY; VALIDATION; ADALIMUMAB; DISEASE;
D O I
10.1007/s10067-018-4238-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Psoriatic arthritis (PsA) is a chronic inflammatory autoimmune arthritis, occurring in patients with psoriasis (Pso), that may affect the whole musculoskeletal system but also nails, eye, and gastrointestinal tract. Dermatologists and rheumatologists usually manage Pso and PsA separately, but early diagnosis and integrated management could achieve better outcomes of both skin and musculoskeletal manifestations, thus improving the health-related quality of life (HRQoL) of patients. In this work, we have described a model of integrated dermo-rheumatologic approach for the early diagnosis of PsA and to present the outcomes of the multidisciplinary management of PsA patients after 48 weeks of follow-up. Pso patients complaining musculoskeletal symptoms were enrolled in a DErmo-Rheumatologic Clinic (DERC) in order to screen, classify, and treat patients with PsA, employing an operative working procedure and a specific flowchart. The integrated dermatologic and rheumatologic management of PsA patients allowed a prompt establishment of the diagnosis and the best therapeutic approach in these patients, with a significant improvement of skin and articular diseases and, eventually, a consistent amelioration of HRQoL. Dermatologists and rheumatologists usually manage the "psoriatic disease" in separated outpatient clinics. In our study, we have demonstrated that a combined DERC, by means of a tight cooperation between the dermatologist and the rheumatologist, which use a specific working procedure and treatment flowchart, may achieve the optimal clinical management of these patients, with a consistent clinical remission of the disease and a significant amelioration of the HRQoL.
引用
收藏
页码:2741 / 2749
页数:9
相关论文
共 50 条
  • [1] Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic
    Michele Maria Luchetti
    Devis Benfaremo
    Anna Campanati
    Elisa Molinelli
    Monia Ciferri
    Serena Cataldi
    William Capeci
    Marco Di Carlo
    Anna Maria Offidani
    Fausto Salaffi
    Armando Gabrielli
    Clinical Rheumatology, 2018, 37 : 2741 - 2749
  • [2] A clinical experience in the early arthritis for psoriatic patients (EARP) screening tool: Screening for psoriatic arthritis in dermatology clinic
    Shepherd, F.
    Lee, A.
    Cooper, A.
    Smith, S. D.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 30 - 30
  • [3] Etanercept versus methotrexate in patients with early rheumatoid arthritis - Two-year radiographic and clinical outcomes
    Genovese, MC
    Bathon, JM
    Martin, RW
    Fleischmann, RM
    Tesser, JR
    Schiff, MH
    Keystone, EC
    Wasko, MC
    Moreland, LW
    Weaver, AL
    Markenson, J
    Cannon, GW
    Spencer-Green, G
    Finck, BK
    ARTHRITIS AND RHEUMATISM, 2002, 46 (06): : 1443 - 1450
  • [4] TWO-YEAR CLINICAL RESPONSE TO BRODALUMAB, AN ANTI-IL-17 RECEPTOR ANTIBODY, IN PATIENTS WITH PSORIATIC ARTHRITIS
    Mease, P.
    Genovese, M. C.
    Greenwald, M. W.
    Ritchlin, C. T.
    Beaulieu, A.
    Deodhar, A.
    Newmark, R.
    Feng, J.
    Erondu, N.
    Nirula, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 136 - 137
  • [5] Two-Year Clinical Response to Brodalumab, an Anti-Interleukin-17 Receptor Antibody, in Patients with Psoriatic Arthritis
    Genovese, Mark C.
    Mease, Philip J.
    Greenwald, Maria
    Ritchlin, Christopher T.
    Beaulieu, Andre
    Deodhar, Atul A.
    Newmark, Richard
    Feng, JingYuan
    Erondu, Ngozi
    Nirula, Ajay
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [6] Two-year data: Infliximab maintains clinical response in psoriatic arthritis patients - An analysis of the year 2 data from the infliximab multinational psoriatic arthritis controlled trial (impact)
    Antoni, CE
    Kavanaugh, A
    Kirkham, B
    Tutuncu, Z
    Burmester, GR
    Schneider, U
    Furst, DE
    Molitor, J
    Keystone, E
    Gladman, D
    Manger, B
    Wassenberg, S
    Weier, R
    Wallace, D
    Weisman, MH
    Kalden, JR
    Smolen, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 82 - 82
  • [7] Clinical remission of psoriatic arthritis in patients receiving continuous biological therapies for 1 year: the experience of an outpatient dermatological clinic for psoriasis
    Graceffa, D.
    Maiani, E.
    Sperduti, I.
    Ceralli, F.
    Bonifati, C.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2015, 40 (02) : 136 - 141
  • [8] DISCONTINUATION OF ETANERCEPT IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION: TWO-YEAR OUTCOME
    Urata, Y.
    Nakamura, Y.
    Motomura, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 525 - 525
  • [9] Two-Year Experience With Latanoprostene Bunod in Clinical Practice
    Radell, Jake E.
    Sharma, Himanshu K.
    Auyeung, Kelsey L.
    Paul, Megan E.
    Gagliuso, Donna J.
    Chadha, Nisha
    Tsai, James C.
    Serle, Janet B.
    JOURNAL OF GLAUCOMA, 2021, 30 (09) : 776 - 780
  • [10] 12 months clinical experience of etanercept in the management of psoriatic arthritis
    Cooney, Martina
    Greenwood, Mandy
    Rathi, Jeetandera
    Rooney, Margaretta
    Tahir, Hasan
    Hakim, Alan J.
    RHEUMATOLOGY, 2008, 47 : II66 - II66